Form 4: United Therapeutics Exec Reports Option Transfer
Statement of Changes in Beneficial Ownership
President and COO Michael Benkowitz transferred 11,728 stock options to a family trust.
Summary
- Michael Benkowitz, President and COO of United Therapeutics, executed a transfer of 11,728 stock options.
- The transaction occurred on May 13, 2026.
- The options were moved from direct ownership to a trust beneficially owned by the reporting person.
- The reporting person retains sole investment and voting power over the trust assets.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it is a routine administrative transfer of ownership between the executive and their controlled trust.
Positives
- The transaction represents a change in holding structure rather than a divestment, indicating continued alignment with company performance.
Negatives
- None identified; this is a routine internal estate planning or administrative transfer.
Risks
- None identified; this filing relates to internal ownership structure changes.
Future Outlook
No forward-looking guidance provided in this filing.
Industry Context
StockSavvy.ai notes that internal transfers of equity to trusts are common among C-suite executives for estate planning purposes and do not typically signal a change in sentiment regarding the company's future prospects.
Comparison to Industry Standards
- The transaction is consistent with standard executive equity management practices observed in the biotechnology sector.
Related Party Transactions
- Transfer of stock options to a trust beneficially owned by the reporting person and his family members.
Stakeholder Impact
- No material impact on shareholders or company operations.
Next Steps
- None
Key Dates
| Date | Description |
|---|---|
| 03/15/2026 | Date options became exercisable. |
| 05/13/2026 | Date of the reported transaction. |
| 05/14/2026 | Date of filing. |
| 03/15/2033 | Expiration date of the stock options. |
Keywords
United Therapeutics, UTHR, Insider Trading, Form 4, Stock Options, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.